Back to Search
GREGORY T KOO MD
MD
General Practice Physician
NPI: 1205895943IndividualAccepts Medicare
Specialties, Licenses & Credentials
Specialist
Specialist
Code: 174400000X
33614(KY)
Family Medicine Physician
Family Medicine
Code: 207Q00000X
33614(KY)
General Practice PhysicianPrimary
General Practice
Code: 208D00000X
33614(KY)
Education
UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE
Class of 1996
Research & Publications (20)
Priming of protective T cell responses against virus-induced tumors in mice with human immune system components.
PMID 19487422·J Exp Med·2009
7-preclinical
Superhydrophobicity of cotton fabrics treated with silica nanoparticles and water-repellent agent.
PMID 19477460·J Colloid Interface Sci·2009
8-other
Discovery of N-{N-[(3-cyanophenyl)sulfonyl]-4(R)-cyclobutylamino-(L)-prolyl}-4-[(3',5'-dichloroisonicotinoyl) amino]-(L)-phenylalanine (MK-0668), an extremely potent and orally active antagonist of very late antigen-4.
PMID 19441819·J Med Chem·2009
7-preclinical
Use of humanized severe combined immunodeficient mice for human vaccine development.
PMID 19093778·Expert Rev Vaccines·2009
6-review
Efficient hydrogen sorption in 8-connected MOFs based on trinuclear pinwheel motifs.
PMID 18459721·Inorg Chem·2008
8-other
Increased but error-prone nonhomologous end joining in immortalized lymphoblastoid cell extracts from adult cancer patients with late radionecrosis.
PMID 18722268·Int J Radiat Oncol Biol Phys·2008
8-other
Characterization of the NOD/scid-[Tg]DR1 mouse expressing HLA-DRB1*01 transgene: a model of SCID-hu mouse for vaccine development.
PMID 17662890·Exp Hematol·2007
7-preclinical
The innate interferon gamma response of BALB/c and C57BL/6 mice to in vitro Burkholderia pseudomallei infection.
PMID 16919160·BMC Immunol·2006
7-preclinical
Potent Kv1.3 inhibitors from correolide-modification of the C18 position.
PMID 15603971·Bioorg Med Chem Lett·2005
8-other
11beta-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice.
PMID 16103409·J Exp Med·2005
7-preclinical
Discovery of 4-heteroarylbicyclo[2.2.2]octyltriazoles as potent and selective inhibitors of 11beta-HSD1: novel therapeutic agents for the treatment of metabolic syndrome.
PMID 16185866·Bioorg Med Chem Lett·2005
7-preclinical
Potent S1P receptor agonists replicate the pharmacologic actions of the novel immune modulator FTY720.
PMID 15149705·Bioorg Med Chem Lett·2004
7-preclinical
A small molecule very late antigen-4 antagonist can inhibit ovalbumin-induced lung inflammation.
PMID 12569079·Am J Respir Crit Care Med·2003
4-observational
Benzamide derivatives as blockers of Kv1.3 ion channel.
PMID 12643934·Bioorg Med Chem Lett·2003
8-other
Acupuncture decreases nitric oxide synthase expression in periaqueductal gray area of rats with streptozotocin-induced diabetes.
PMID 12536047·Neurosci Lett·2003
4-observational
N-isonicotinoyl-(L)-4-aminophenylalanine derivatives as tight binding VLA-4 antagonists.
PMID 12749892·Bioorg Med Chem Lett·2003
7-preclinical
Identification of a new class of inhibitors of the voltage-gated potassium channel, Kv1.3, with immunosuppressant properties.
PMID 12056910·Biochemistry·2002
7-preclinical
Model of differential susceptibility to mucosal Burkholderia pseudomallei infection.
PMID 11796576·Infect Immun·2002
4-observational
Modulation of Chelidonii herba on GABA activated chloride current in rat PAG neurons.
PMID 11527069·Am J Chin Med·2001
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via HEALTHFIRST BLUEGRASS INC. · 2 locations total
- Address
- 1401 HARRODSBURG RD STE B165
LEXINGTON, KY 40504 - Phone
- (859) 288-2425
Quick Facts
- NPI
- 1205895943
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 2
- Years in Practice
- 30
- Publications
- 20
Are you this provider?
Claim Your Profile